Powerful mRNA vaccine to tackle malaria
The mRNA-based vaccine can effectively target and stimulate protective immune cell responses against the malaria-causing parasite <em>Plasmodium</em> in preclinical models.
Source: labonline.com.au
Ferrier Institutes News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ferrier Institutes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ferrier Institutes Today - Breaking & Trending Today
Scientific breakthrough harnesses mRNA technology to develop powerful malaria vaccine
A new mRNA vaccine targeting immune cells in the liver could be the key to tackling malaria, a disease that causes over half a million deaths each year according to the World Health Organization, yet has no effective long-lasting vaccine
Source: nzdoctor.co.nz
Health News | Scientific Breakthrough Uses MRNA Technology to Create a Highly Effective Malaria Vaccine
Get latest articles and stories on Health at LatestLY. In preclinical models, Trans-Tasman research collaborators from Te Herenga Waka—Victoria University of Wellington's Ferrier Research Institute and the Malaghan Institute of Medical Research in New Zealand and the Peter Doherty Institute for Infection and Immunity in Australia developed an mRNA-based vaccine that can effectively target and stimulate protective immune cell responses against the malaria-causing parasite Plasmodium. Health News | Scientific Breakthrough Uses MRNA Technology to Create a Highly Effective Malaria ...
Source: latestly.com
Business.Scoop » Scientific Breakthrough Harnesses mRNA Technology To Develop Powerful Malaria Vaccine
Business Scoop provides news and views on Business and Markets from New Zealand
Source: scoop.co.nz
New mRNA-based malaria vaccine shows promise in preclinical trials
Trans-Tasman research collaborators from Te Herenga Waka-; Victoria University of Wellington's Ferrier Research Institute and the Malaghan Institute of Medical Research in New Zealand, and the Peter Doherty Institute for Infection and Immunity in Australia have developed an mRNA-based vaccine that can effectively target and stimulate protective immune cell responses against the malaria-causing parasite Plasmodium in preclinical models.
Source: news-medical.net